Life Sciences

“Not until I dealt with Kaye Scholer did I come to recognize a new level of client service existed and was willingly provided.”—Chambers USA 2013 (Nationwide: Life Sciences)

Kaye Scholer’s multidisciplinary Life Sciences Group represents pharmaceutical, medical device, biotech and health tech firms in every stage of a product’s life cycle. We take a holistic approach in addressing the issues and exploiting the opportunities that affect the very foundations of your business.

We have deep experience starting at the licensing and commercialization stage, carrying through to disputes concerning those agreements, marketing, intellectual property disputes and product liability litigation. Whether it’s the structuring of a complex drug development deal, negotiating an acquisition, protecting intellectual property, minimizing exposure to mass tort liability, resolving complex biotech disputes or defending high-stakes government investigations, the business of life sciences and the development and commercialization of health technology is deeply ingrained in the firm’s DNA, touching nearly every area of our practice. Our firm is set apart by our deep knowledge of the business and commercial needs of life sciences companies, drawing on more than 40 years of experience advising in the industry.

As a result of our experience and track record of success, we are recognized by Chambers USA 2013 as a leading firm for Life Sciences and by U.S. News-Best Lawyers “Best Law Firms” 2013 in Tier 1 for Biotechnology Nationwide. Chambers also names us as one of the top six firms in the nation for client service and one of the top three firms in the country for commercial awareness in the industry. Our life sciences practice is also recognized by The Legal 500, LMG Life Sciences and Managing IP Handbook, among others.